Cargando…
Access and Benefit Sharing Under the Nagoya Protocol—Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk
BACKGROUND: Global challenges related to access and benefit sharing (ABS) of biological resources have become a key concern in the area of research on herbal medicines, ethnopharmacology, drug discovery, and the development of other high value products for which Intellectual Property protection can...
Autores principales: | Heinrich, Michael, Scotti, Francesca, Andrade-Cetto, Adolfo, Berger-Gonzalez, Monica, Echeverría, Javier, Friso, Fabio, Garcia-Cardona, Felipe, Hesketh, Alan, Hitziger, Martin, Maake, Caroline, Politi, Matteo, Spadafora, Carmenza, Spadafora, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294742/ https://www.ncbi.nlm.nih.gov/pubmed/32581783 http://dx.doi.org/10.3389/fphar.2020.00765 |
Ejemplares similares
-
Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023) -
Quo vadis precision oncology?
por: Heinrich, Kathrin, et al.
Publicado: (2023) -
Quo vadis?
por: Sienkiewicz, Henryk, 1846-1916
Publicado: (1943) -
“Quo Vadis?”
por: Bereen, J. F.
Publicado: (1964) -
Quo vadis? /
por: Sienkiewicz, Henryk, 1846-1916